Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Evaluation of bone marrow mononuclear cells as an adjunct therapy to minced muscle graft for the treatment of volumetric muscle loss injuries

Fig. 1

Using a rat model of VML, we tested the hypothesis that bone marrow mononuclear cells (BMNCs) directly contribute to de novo muscle fiber regeneration, by transplanting MG in a collagen carrier at a dose of 50% of the VML injury both with and without concomitant delivery of 5 million BMNCs derived via density gradient centrifugation from the bone marrow of a syngeneic greens fluorescent protein (GFP)+ donor. RBC red blood cell

Back to article page